Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q1 2021 Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer Conference Call Participants Justin Kim - Oppenheimer Kelly Shi - Jefferies Marc Goodman - SVB Leerink Edwin Zhang - H.C. Wainwright Esther Hong - Berenberg Prakhar Agrawal - JonesTrading Yale Jen - Laidlaw & Company Operator Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therap ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q4 2020 Earnings Conference Call March 11, 2021 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer Conference Call Participants Yigal Nochomovitz - Citigroup Louise Chen - Cantor Fitzgerald Kelly Shi - Jefferies Justin Kim - Oppenheimer Matthew Cross - Alliance Global Partners Julian Harrison - BTIG Esther Hong - Berenberg Edwin Zhang - H.C. Wainwright Prakhar Agrawal - JonesTrading Yale Jen - Laidla ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36332 ALDEYRA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 20-1968197 (State or othe ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer David McMullin - Chief Business Officer Conference Call Participants Samantha Semenkow - Citi Jennifer Kim - Cantor Fitzgerald Jackie Yan - Oppenheimer Matt Cross - Alliance Global Partners Julian Harrison - BTIG Kelly Shi - Jefferies Operator Good morning and welcome to the Aldeyra Therapeuti ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET Company Participants Joshua Reed - CFO Todd Brady - CEO, President & Director Conference Call Participants Louise Chen - Cantor Fitzgerald & Co. Justin Kim - Oppenheimer Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions]. I would now like to introduce the company's Chief Financial Offi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36332 ALDEYRA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 20-1968197 (State or other jur ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) COVID-19 Development Update Conference Call May 19, 2020 8:10 AM ET Company Participants Joshua Reed – Chief Financial Officer Todd Brady – President and Chief Executive Officer Adam Brockman – Director-Non-Clinical Development Conference Call Participants Louise Chen – Cantor Justin Kim – Oppenheimer Yigal Nochomovitz – Citigroup Yale Jen – Laidlaw & Company Esther Hong – Janney Matthew Cross – JonesTrading Operator Ladies and gentlemen, thank you for standing by an ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q1 2020 Results Earnings Conference Call May 7, 2020 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Dr. Todd Brady - President and CEO David McMullin - Chief Commercial Officer Conference Call Participants Samantha Semenkow - Citi Carvey Leung - Cantor Esther Hong - Janney Matthew Cross - Jones Trading Operator Good morning. And welcome to the Aldeyra Therapeutics First Quarter 2020 Financial Results Conference Call. After the speaker’ remarks, ...